Loading...
NPI 1366686800 · Durango, CO · Podiatrist
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Kayse Lake is a podiatrist provider located in Durango, Colorado. This profile covers 21 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Kayse Lake |
| Address | 1266 Escalante Dr |
| City | Durango |
| State | CO |
| ZIP | 81303 |
| Taxonomy | Podiatrist |
| NPI Enumerated | April 28, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.3M |
| Medicaid | $790 |
KAYSE LAKE is a long-tenured provider in Durango, CO, with an NPI enumerated on 2009-04-28 (~17 years ago), indicating an established practice history that likely supports consistent Medicare billing relationships over time. The longevity aligns with a sustained Medicare revenue stream rather than a recent entrant profile.
Medicare dominates this provider’s public payer footprint: total Medicare revenue of $1.3M dwarfs Medicaid receipts of $791, so the practice is effectively Medicare-centric rather than balanced across public payers. Medicaid activity is negligible in scale compared with Medicare, making the provider effectively single-payer by revenue.
Revenue concentration on Medicare is extremely high: the precomputed top 3 Medicare codes account for 91.1% of this provider’s total Medicare revenue, signaling that a small set of services drive nearly all Medicare dollars for this NPI. This concentration implies operational focus on the procedures represented by those top codes rather than a broad, diversified Medicare service mix.
The single largest Medicare revenue driver is Q4262 (Dual layer impax membrane), which accounts for $935.4K and 72.4% of Medicare revenue. That dominant share indicates the practice generates most of its Medicare income from procedures involving dual-layer wound/skin substitute products, suggesting a service-line emphasis on advanced wound care or graft/substitute applications.
Two additional Medicare lab codes, 87798 and 87801, together account for a sizeable portion of the remaining Medicare revenue (12.6% and 6.1% respectively), showing substantial diagnostic testing volume alongside the primary procedure mix. High claim counts reported for 87798 (4.8K claims) and 87801 (1.1K claims) indicate the practice performs these amplified nucleic acid probe tests at scale, consistent with a hybrid model that pairs procedural wound-care work with on-site or ordered infectious disease testing.
On competitive standing, Q4262 ranks #97 of 141 providers nationally (31st percentile), which the data labels as typical and unremarkable—this provider is not a national leader for that code despite the large revenue share it generates for them. Conversely, for E/M and other general office visit codes like 99213, the provider ranks at the 95th percentile nationally (notably above typical), indicating above-typical volume for routine outpatient evaluation visits relative to all providers.
At the state Medicaid level, the provider’s Medicaid revenue is almost entirely concentrated in one code: 11721 accounts for 100.0% of Medicaid revenue ($742). With 106 Medicaid claims for 11721 and a state rank of #48 of 71 (33rd percentile), the provider is a modest in-state participant for that procedure rather than a dominant Medicaid supplier. This reinforces the observation that Medicaid is not a meaningful revenue source for this NPI.
Several Medicare codes show typical, unremarkable national volumes (e.g., 87481, 11755, 11721) and many common podiatry-related codes appear on the list (nail biopsies 11755, nail debridement 11721, nail removal 11750), which together with imaging codes (73630) and debridement/skin substitute codes (15275, 11042) paint a consistent clinical picture. The mix supports an ambulatory podiatry practice that combines procedural wound/nail care with diagnostic testing and imaging.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
21 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| Q4262 | Dual layer impax membrane, per square centimeter (add-on, list separately in addition to primary procedure) | 880 | $1,060 | $935.4K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 4,770 | $30 | $162.2K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 1,130 | $70 | $78.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 550 | $60 | $34.9K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 740 | $30 | $25K |
| 11755 | This procedural code is used when the physician biopsies the nail plate, bed, hyponychium, proximal nail folds, or lateral nail folds. Each one is a separate procedure. | 120 | $90 | $10.9K |
| 11721 | The provider surgically debrides (debulks or removes) 6 or more abnormal, diseased, or infected nails. | 320 | $30 | $10.1K |
| 15275 | The provider uses a skin substitute, such as an allograft or xenograft, to cover wounds on the face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, up to… | 80 | $120 | $9.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 110 | $80 | $8.8K |
| 73630 | In this diagnostic procedure, the provider takes a minimum of three views of the foot to assess injury, fracture, arthritis, tumor, or congenital abnormality. | 150 | $30 | $3.8K |
Showing 1–10 of 21
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 11721 | The provider surgically debrides (debulks or removes) 6 or more abnormal, diseased, or infected nails. | 110 | $10 | $740 |
How this provider's Medicaid billing volume and revenue compare to other Colorado providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Colorado median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 11721 | The provider surgically debrides (debulks or removes) 6 or more abnormal, diseased, or infected nails. | 48 | 70 | 310 | $20 | $20.7K |
Other providers in the same ZIP code as Kayse Lake, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.